[The progress of chemotherapy for advanced pancreatic cancer]

Nihon Shokakibyo Gakkai Zasshi. 2015 Dec;112(12):2119-26. doi: 10.11405/nisshoshi.112.2119.
[Article in Japanese]
No abstract available

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Drug Combinations
  • Erlotinib Hydrochloride / therapeutic use
  • Fluorouracil / therapeutic use
  • Gemcitabine
  • Humans
  • Leucovorin / therapeutic use
  • Organoplatinum Compounds / therapeutic use
  • Oxonic Acid / therapeutic use
  • Pancreatic Neoplasms / drug therapy*
  • Tegafur / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Drug Combinations
  • Organoplatinum Compounds
  • Deoxycytidine
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Erlotinib Hydrochloride
  • Leucovorin
  • Fluorouracil
  • Gemcitabine

Supplementary concepts

  • Folfox protocol